AIM

AIM ImmunoTech Inc

$0.17

0.00 (2.06%) Today

— up— down

Compare AIM

Market Cap

$7M-93.5%

Revenue (TTM)

$152.46K-21.5%

Net Income (TTM)

$-108,947,916

EPS (TTM)

-3.93

Shares Out

27.72M

Open

$0.17

Previous Close

$0.17

Day Range

$0.17 – $0.18

52-Week Range

$0.17 – $2.79

Beta

1.36

Earnings Date

Nov 16, 2026

Volume

2.56M

Avg Volume

16.79M

Analyst Rating

Buy

Exchange

NYSE MKT LLC

About AIM

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.